Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Clinical Data
  • Beam posts positive data on base editing treatment for AATD
  • Clinical Data

Beam posts positive data on base editing treatment for AATD

BioPharma Dive

Updated data showed the biotech's approach to the rare lung and liver condition helped restore functional protective proteins in a small study.

Clinical DataRare DiseaseRead full story

pharminent March 25, 2026 (Last updated: March 26, 2026)

BioPharma Dive

Updated data showed the biotech’s approach to the rare lung and liver condition helped restore functional protective proteins in a small study.

Clinical DataRare DiseaseRead full story

Post navigation

Previous: Sarepta sees early success with RNAi drugs from Arrowhead
Next: Maze tumbles despite positive data for kidney disease drug

Related Stories

  • Clinical Data

Novo Nordisk starts trialing lower maintenance doses of oral Wegovy

pharminent August 21, 2026
  • Clinical Data

Cancer vaccine win restores Wall Street’s faith in Moderna

pharminent August 20, 2026
  • Clinical Data

New Taiho, Cullian data heats up lung cancer drug battle

pharminent August 13, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.